Back to Search
Start Over
Drug resistant Mycobacterium tuberculosis strains have altered cell envelope hydrophobicity that influences infection outcomes in human macrophages.
- Source :
-
Scientific reports [Sci Rep] 2024 Dec 28; Vol. 14 (1), pp. 30840. Date of Electronic Publication: 2024 Dec 28. - Publication Year :
- 2024
-
Abstract
- In recent decades, drug resistant (DR) strains of Mycobacterium tuberculosis (M.tb), the cause of tuberculosis (TB), have emerged that threaten public health. Although M.tb's complex and protective cell envelope has been widely studied, little is known about how levels of peripheral lipids change in relation to drug resistance. In this study, we examined levels of cell envelope lipids [phthiocerol dimycocerosates (PDIMs)], glycolipids [phosphatidyl-myo-inositol mannosides (PIMs)], and PIMs associated lipoglycans [lipomannan (LM); mannose-capped lipoarabinomannan (ManLAM)] of 22 M.tb strains that ranged in drug resistance profile. We show that the PDIMs:PIMs ratio increases as drug resistance increases, and provide evidence of PDIM isomers only present in the DR-M.tb strains studied. Overall, the LM and ManLAM levels did not differ between drug resistance categories, but ManLAM surface exposure increased with drug resistance. Infection of human macrophages revealed that DR-M.tb strains have decreased association compared to drug susceptible (DS) strains, and that the pre-XDR M.tb strain with the largest PDIMs:PIMs ratio had decreased uptake, but increased intracellular growth at early during infection compared to the DS-M.tb strain H <subscript>37</subscript> R <subscript>v</subscript> . These findings suggest that PDIMs may play an important role in drug resistance and that an increase in hydrophobic cell envelope lipids may influence M.tb-host interactions.<br />Competing Interests: Declarations. Competing interests: The authors declare no competing interests. Biosafety and ethical approval: These studies were approved by our institutional BioSafety Committee (BSC) protocol number BSC-22–018 and by our Human Subjects Institutional Review Board (IRB) protocol number 20170315HU (UT-Health San Antonio) as described in our Materials and Methods.<br /> (© 2024. The Author(s).)
- Subjects :
- Humans
Phosphatidylinositols metabolism
Cell Membrane metabolism
Cell Membrane drug effects
Drug Resistance, Bacterial
Antitubercular Agents pharmacology
Glycolipids pharmacology
Glycolipids metabolism
Tuberculosis, Multidrug-Resistant microbiology
Tuberculosis, Multidrug-Resistant drug therapy
Lipids
Mycobacterium tuberculosis drug effects
Macrophages microbiology
Macrophages metabolism
Macrophages drug effects
Hydrophobic and Hydrophilic Interactions
Cell Wall metabolism
Cell Wall drug effects
Lipopolysaccharides metabolism
Subjects
Details
- Language :
- English
- ISSN :
- 2045-2322
- Volume :
- 14
- Issue :
- 1
- Database :
- MEDLINE
- Journal :
- Scientific reports
- Publication Type :
- Academic Journal
- Accession number :
- 39730579
- Full Text :
- https://doi.org/10.1038/s41598-024-81457-0